Intranasal Diuretic for the Treatment of CHF Refractory to Oral Diuretics. Have Completed our IND Opening Study Which Demonstrated Similar Bioavailability vs Oral and IV Formulations. Our Product Is Intended to Act as an Outpatient Option for Patients…
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Industry Salary/Salary Support/Employee (full time or part time) - Corstasis Therapeutics
- CEO - Acutus Medical